A Multiple Ascending Dose Study of LW402 in Healthy Volunteers

NCT07546149 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Safety Evaluation of Escalating Doses

Interventions

DRUG: Experimental
DRUG: Placebo

Sponsor

Shanghai Longwood Biopharmaceuticals Co., Ltd.